Endo International (ENDP) Tops Q2 EPS by 22c, Lifts FY Guidance

Endo International (NASDAQ: ENDP) reported Q2 EPS of $0.76, $0.22 better than the analyst estimate of $0.54. Revenue for the quarter came in at $715 million versus the consensus estimate of $678.35 million.

GUIDANCE:

Endo International sees FY2018 EPS of $2.50-$2.60, versus the consensus of $2.42. Endo International sees FY2018 revenue of $2.75-2.85 billion, versus the consensus of $2.75 billion.

For earnings history and earnings-related data on Endo International (ENDP) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• Innovaro (INV) Misses Q2 EPS by 9c